|
COQ5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.26419999602857E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.94469999951153E-07 |
| Normal-vs-Stage2 |
8.171000E-01 |
| Normal-vs-Stage3 |
9.89799997519469E-09 |
| Normal-vs-Stage4 |
1.74329994884204E-10 |
| Stage1-vs-Stage2 |
4.973300E-04 |
| Stage1-vs-Stage3 |
5.524100E-02 |
| Stage1-vs-Stage4 |
1.557200E-03 |
| Stage2-vs-Stage3 |
6.34360000000278E-05 |
| Stage2-vs-Stage4 |
1.4674999999631E-06 |
| Stage3-vs-Stage4 |
1.628410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.21190000257343E-08 |
| Normal-vs-AfricanAmerican |
3.656700E-03 |
| Normal-vs-Asian |
4.45040000000008E-05 |
| Caucasian-vs-AfricanAmerican |
9.971800E-01 |
| Caucasian-vs-Asian |
5.863200E-01 |
| AfricanAmerican-vs-Asian |
7.511400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63880000014771E-07 |
| Normal-vs-Female |
7.33749999981548E-07 |
| Male-vs-Female |
1.482980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.90290000002503E-07 |
| Normal-vs-Age(41-60Yrs) |
2.7953000000247E-06 |
| Normal-vs-Age(61-80Yrs) |
3.77070000000534E-05 |
| Normal-vs-Age(81-100Yrs) |
4.082800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.958800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.550600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.931400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.347600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.844600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.186200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.529950E-02 |
| Classical-VS-Follicular |
1.10140000009196E-07 |
| Classical-VS-Other |
6.774800E-01 |
| Classical-VS-Normal |
5.95289995075632E-09 |
| Tall-VS-Follicular |
1.75259995405241E-09 |
| Tall-VS-Other |
3.650000E-01 |
| Tall-VS-Normal |
9.15040043736326E-10 |
| Follicular-VS-Other |
1.720220E-01 |
| Follicular-VS-Normal |
9.481800E-01 |
| Other-VS-Normal |
5.004100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.795200E-04 |
| Normal-vs-N1 |
1.3221646000261E-12 |
| N0-vs-N1 |
2.11160000040955E-07 |
|
|
